B. Riley Securities initiated coverage on Scilex Holding with a new price target
$SCLX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
B. Riley Securities initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $4.00